UK vehicle production continues to face constraints, with figures from the Society of Motor Manufacturers and Traders (SMMT) ...

Summit Therapeutics Inc. (NASDAQ:SMMT) ranks among the 30 stocks expected to beat the market by 20 percentage points this ...

Summit Therapeutics (SMMT) stock gains as AstraZeneca (AZN) is said to eye its lung cancer drug ivonescimab, a potential ...

As a result, Britain say the strongest June for new car sales since 2019, with 191,316 cars registered, according to the ...

The new car market recorded its second consecutive month of growth in June, with registrations rising 6.7% year-on-year ...

UK EV market expands, but rising costs, Chinese competition, and lagging infrastructure are slowing the industry.

Fintel reports that on July 1, 2025, UBS initiated coverage of Summit Therapeutics (NasdaqGM:SMMT) with a Buy recommendation.

Summit Therapeutics nears a $15B AstraZeneca deal for ivonescimab, targeting a $90B market. See more on the potential and ...

Summit Therapeutics Inc. (NASDAQ:SMMT) is one of the best hot stocks to buy according to Wall Street analysts.

Tesla's new car sales in Britain rose year-on-year in June amid a broader recovery in the electric-vehicle market, data ...

Sales remained below pre-COVID levels, but it was the best June since 2019, the Society of Motor Manufacturers and Traders ...

Britain's auto industry is facing its worst downturn in decades, with May vehicle production plunging 32.8 percent ...